SP

Shreenidhi Panigrahi

Active Director Director DIN 10325359
DIN 10325359 First appointment Sep 2023 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Shreenidhi Panigrahi

Data last updated:

Shreenidhi Panigrahi is a Director at Sai Medaax Private Limited (since 2023). The company operates in Healthcare.

DIN 10325359
Primary Designation Director
Industry Healthcare
First Appointment 17 Sep 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sai Medaax Private Limited U86100OD2023PTC043763
Director17 Sep 20232023Active

Board colleagues of Shreenidhi Panigrahi

NameDINCompanyDesignation
Shreyas Panigrahi10325358Sai Medaax Private LimitedDirector
Sunayana Panigrahi10325360Sai Medaax Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Sai Medaax Private Limited
Premium access

Shareholding and investment profile for Shreenidhi Panigrahi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shreenidhi Panigrahi

Shreenidhi Panigrahi currently holds 1 directorship: Sai Medaax Private Limited (Director, since 17 Sep 2023).

Shreenidhi Panigrahi was first appointed on 17 Sep 2023 as Director at Sai Medaax Private Limited.

The current boards of Shreenidhi Panigrahi's companies include Shreyas Panigrahi (Sai Medaax Private Limited), Sunayana Panigrahi (Sai Medaax Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available